Nephroblastoma belongs to malignant tumors, which can not be completely cured, but after regular systematic treatment, it can reach the standard of clinical cure, and the survival rate of 4 years after surgery is 75%～85%.
There are many factors affecting the prognosis, including age and tumor size, pathological type and degree of differentiation, whether there is metastasis and the way of metastasis, etc. At present, nephroblastoma is mainly treated with surgery, chemotherapy, radiotherapy and other measures for comprehensive treatment with relatively good results.
Nephroblastoma is one of the malignant tumors that develops in infancy and childhood, and is prone to lung metastasis and lymph node metastasis. Early detection and treatment will be helpful to improve the prognosis. With standardized treatment, the 4-year survival rate is about 75% to 85%.
Retinoblastoma is recommended to seek timely medical attention and early treatment to avoid delaying the disease.